SWOG S0221: A Phase III Trial Comparing Chemotherapy Schedules in High-Risk Early-Stage Breast Cancer

PURPOSE: To determine the optimal dose and schedule of anthracycline and taxane administration as adjuvant therapy for early-stage breast cancer. PATIENTS AND METHODS: A 2 × 2 factorial design was used to test two hypotheses: (1) that a novel continuous schedule of doxorubicin-cyclophosphamide was s...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Clin Oncol
Päätekijät: Budd, George T., Barlow, William E., Moore, Halle C.F., Hobday, Timothy J., Stewart, James A., Isaacs, Claudine, Salim, Muhammad, Cho, Jonathan K., Rinn, Kristine J., Albain, Kathy S., Chew, Helen K., Burton, Gary V., Moore, Timothy D., Srkalovic, Gordan, McGregor, Bradley A., Flaherty, Lawrence E., Livingston, Robert B., Lew, Danika L., Gralow, Julie R., Hortobagyi, Gabriel N.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Clinical Oncology 2015
Aiheet:
ORIGINAL REPORTS
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4268253/
https://ncbi.nlm.nih.gov/pubmed/25422488
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.56.3296
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia